Levocetirizine Dihydrochloride

Producer:Chongqing Huapont Shengchem Pharm Co., Ltd. (Hereafter called Huapont Pharm.) is a leading dermatological drug manufacturer in China. Huapont Pharm was established in 1992 by Dr Songshan Zhang, now he is a member of of Huapont Life Science Co., Ltd. which is a non-state owned public company listed in Shenzhen Stock Exchange since 2004.

With over 25 years’ development, Huapont Pharm rely on science and technology, continually provide the highly effective medicines and service to patients and society. From a leading manufacturer of dermatological drugs and gradually expand the product mix to respiratory system drugs, drugs for tumors, drugs for TB and drugs treating cardio-cerebrovascular diseases, etc. Both the finished dosage forms (FDFs) and active pharmaceutical ingredients (APIs) are manufactured and supplied to the domestic and international market. 

The API facility of Huapont Pharm has become an exporting base of APIs, where of GMP has inspected and approved by US-FDA, MEDSAFE, COFEPRIS, other countries authorities and number of customers. 

Staff size:300-399 persons

Registered capital:RMB 100 million

Producer:Zhejiang Yongning Pharmaceutical Co., Ltd., located in Taizhou, Zhejiang Province, has more than 100 product varieties in five categories, including chemical agents, chemical pharmaceutical intermediates, APIs, Chinese patent medicines and health products.   The company has fully passed the new national GMP certification, and some products have passed the certification of FDA, PMDA of Japan and KFDA of Korea, among which cefotiam hydrochloride is the standard of USP.
Staff size:900-999 persons

Registered capital:RMB 153.125 million

Producer:Fu'an Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd., a subsidiary of Fu'an Pharmaceutical (Group) Co., Ltd., is the production base of antitumor API of the group. Founded in August 1992, Tianheng has been engaged in the pharmaceutical industry for more than 20 years and has fully passed the national GMP certification. The enterprise has national first-class medical science and technology strength and medical science and technology research center.

Staff size:400-499 persons

Registered capital:RMB 415 million

Producer:Jiangsu Hengrui Medicine Co.,Ltd. is a pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs. 

The company has 28000 employees globally, fifth R & D centers were built around the globe and several subsidiaries were established in the US, EU, and Japan.

The company has 10 manufacturing facilities and most of them maintain USP, EUP, and JP. We are the first Chinese company that exported injections on a large scale to the US, EU, and Japan markets. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesilar and tiotepa have passed the verification of FDA.

Staff size:About 30000 persons

Registered capital:RMB 6 billion 397 million

Producer:Hunan Jiudian Pharmaceutical Co., Ltd. is a listed pharmaceutical enterprise integrating drug R & D, production and sales. It was incorporated in 2001 and listed on the gem in 2017.

The company has completed the all-round layout of pharmaceutical preparations, traditional Chinese medicine, APIs, pharmaceutical accessories, pharmaceutical commerce and other industries, established a perfect R & D, marketing and production system, and continuously improved the level of operation and management; R & D resources and market resources are increasingly abundant. It has modern production lines including raw material medicine, oral solid preparation, oral liquid preparation, gel paste, pharmaceutical excipient and so on. Preparations and traditional Chinese medicine are produced in Liuyang Economic Development Zone, APIs and excipients are produced in Wangcheng Economic Development Zone, and R & D and commercial sales are in Changsha high tech Zone.

The company is a R & D driven enterprise with sound R & D system and advanced instruments and equipment. It has more than 10000 square meters of research and development sites, forming a complete test platform from small-scale research to pilot test to industrialization. A 400 person R & D team with doctors, masters and returned overseas talents as the main body has been established, with the strongest R & D level in the province. The company's leading products are self-developed. There are nearly 100 products under research and declared products, which will greatly enrich the company's product pipeline. After the new drugs under research are listed, they will become a heavy variety of existing advantageous products.

Staff size:About 1500 persons

Registered capital:RMB 234 million 700 thousand

Producer:Shanghai Qingsong Pharmaceutical Co., Ltd. is a pharmaceutical enterprise controlled by CITIC Industrial Fund. It is a high-tech enterprise rapidly developing in the fields of pharmaceutical raw materials, pharmaceutical preparations, pharmaceutical intermediates, chemical process contract research services and customized synthesis. The company has passed GMP, ISO9002 and ISO14001 certification.

Staff size:About 50 persons

Registered capital:RMB 87.5002 million

The company is now deregistered.

Staff size:/

Registered capital:RMB 50 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978